Medicenna Therapeutics Cor Shares Outstanding vs. Market Capitalization
| MDNA Stock | CAD 1.13 0.02 1.74% |
For Medicenna Therapeutics Cor profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medicenna Therapeutics Cor to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medicenna Therapeutics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medicenna Therapeutics Cor's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medicenna Therapeutics Corp over time as well as its relative position and ranking within its peers.
Medicenna |
Medicenna Therapeutics Cor Market Capitalization vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medicenna Therapeutics Cor's current stock value. Our valuation model uses many indicators to compare Medicenna Therapeutics Cor value to that of its competitors to determine the firm's financial worth. Medicenna Therapeutics Corp is considered to be number one stock in shares outstanding category among its peers. It also is considered to be number one stock in market capitalization category among its peers creating about 1.13 of Market Capitalization per Shares Outstanding. At this time, Medicenna Therapeutics Cor's Market Cap is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Medicenna Therapeutics Cor by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medicenna Therapeutics Cor's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Medicenna Market Capitalization vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Medicenna Therapeutics Cor |
| = | 78.22 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Medicenna Therapeutics Cor |
| = | 88.38 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Medicenna Market Capitalization vs Competition
Medicenna Therapeutics Corp is considered to be number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 231.61 Million. Medicenna Therapeutics Cor totals roughly 88.38 Million in market capitalization claiming about 38% of equities under Health Care industry.
Medicenna Therapeutics Cor Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medicenna Therapeutics Cor, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medicenna Therapeutics Cor will eventually generate negative long term returns. The profitability progress is the general direction of Medicenna Therapeutics Cor's change in net profit over the period of time. It can combine multiple indicators of Medicenna Therapeutics Cor, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 17.1 K | 16.2 K | |
| Operating Income | -17.7 M | -16.8 M | |
| Net Loss | -22.9 M | -21.8 M | |
| Income Before Tax | -22.9 M | -21.8 M | |
| Total Other Income Expense Net | -5.2 M | -5 M | |
| Net Loss | -9 M | -9.5 M | |
| Net Loss | -22.9 M | -21.8 M | |
| Income Tax Expense | -10.4 M | -9.9 M | |
| Net Interest Income | 1.4 M | 1.4 M | |
| Interest Income | 1.4 M | 1.2 M | |
| Change To Netincome | -5.8 M | -5.5 M | |
| Net Loss | (0.42) | (0.44) | |
| Income Quality | 0.73 | 1.28 | |
| Net Loss | (0.18) | (0.17) |
Medicenna Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medicenna Therapeutics Cor. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medicenna Therapeutics Cor position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medicenna Therapeutics Cor's important profitability drivers and their relationship over time.
Use Medicenna Therapeutics Cor in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medicenna Therapeutics Cor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics Cor will appreciate offsetting losses from the drop in the long position's value.Medicenna Therapeutics Cor Pair Trading
Medicenna Therapeutics Corp Pair Trading Analysis
The ability to find closely correlated positions to Medicenna Therapeutics Cor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medicenna Therapeutics Cor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medicenna Therapeutics Cor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medicenna Therapeutics Corp to buy it.
The correlation of Medicenna Therapeutics Cor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medicenna Therapeutics Cor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medicenna Therapeutics Cor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medicenna Therapeutics Cor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medicenna Therapeutics Cor position
In addition to having Medicenna Therapeutics Cor in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate ETFs Thematic Idea Now
Corporate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Corporate ETFs theme has 222 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Medicenna Stock
To fully project Medicenna Therapeutics Cor's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Medicenna Therapeutics Cor at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Medicenna Therapeutics Cor's income statement, its balance sheet, and the statement of cash flows.